Manufacturer's investigation conclusion: a specific cause for the reported events and patient outcome, as well as a direct correlation to heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(4), could not be conclusively determined through this evaluation.It was reported that hm3 lvas, serial number (b)(4), would not be returned for evaluation.The hm3 lvas ifu, rev.C, is currently available.Section 1 of the ifu lists respiratory failure, stroke, and death as potential adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6 of the ifu, under ¿anticoagulation¿, provides information regarding the recommended anticoagulation therapy and inr range, as well as suggested anticoagulation modifications.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 06 mar 2022.No further information was provided.The manufacturer is closing the file on this event.
|